Rapid production and free distribution of a synthetic RNA material to support SARS-CoV-2 molecular diagnostic testing

IF 1.5 4区 生物学 Q4 BIOCHEMICAL RESEARCH METHODS Biologicals Pub Date : 2023-05-01 DOI:10.1016/j.biologicals.2023.101680
Megan H. Cleveland, Erica L. Romsos, Carolyn R. Steffen, Nathan D. Olson, Stephanie L. Servetas, William G. Valiant, Peter M. Vallone
{"title":"Rapid production and free distribution of a synthetic RNA material to support SARS-CoV-2 molecular diagnostic testing","authors":"Megan H. Cleveland,&nbsp;Erica L. Romsos,&nbsp;Carolyn R. Steffen,&nbsp;Nathan D. Olson,&nbsp;Stephanie L. Servetas,&nbsp;William G. Valiant,&nbsp;Peter M. Vallone","doi":"10.1016/j.biologicals.2023.101680","DOIUrl":null,"url":null,"abstract":"<div><p>In response to the COVID-19 pandemic, the National Institute of Standards and Technology released a synthetic RNA material for SARS-CoV-2 in June 2020. The goal was to rapidly produce a material to support molecular diagnostic testing applications. This material, referred to as Research Grade Test Material 10169, was shipped free of charge to laboratories across the globe to provide a non-hazardous material for assay development and assay calibration. The material consisted of two unique regions of the SARS-CoV-2 genome approximately 4 kb nucleotides in length. The concentration of each synthetic fragment was measured using RT-dPCR methods and confirmed to be compatible with RT-qPCR methods. In this report, the preparation, stability, and limitations of this material are described.</p></div>","PeriodicalId":55369,"journal":{"name":"Biologicals","volume":"82 ","pages":"Article 101680"},"PeriodicalIF":1.5000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154543/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biologicals","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1045105623000180","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

In response to the COVID-19 pandemic, the National Institute of Standards and Technology released a synthetic RNA material for SARS-CoV-2 in June 2020. The goal was to rapidly produce a material to support molecular diagnostic testing applications. This material, referred to as Research Grade Test Material 10169, was shipped free of charge to laboratories across the globe to provide a non-hazardous material for assay development and assay calibration. The material consisted of two unique regions of the SARS-CoV-2 genome approximately 4 kb nucleotides in length. The concentration of each synthetic fragment was measured using RT-dPCR methods and confirmed to be compatible with RT-qPCR methods. In this report, the preparation, stability, and limitations of this material are described.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
快速生产和免费分发合成RNA材料,以支持SARS-CoV-2分子诊断检测
为应对COVID-19大流行,美国国家标准与技术研究院于2020年6月发布了一种针对SARS-CoV-2的合成RNA材料。目标是快速生产一种支持分子诊断测试应用的材料。该材料,被称为研究级测试材料10169,免费运送到全球各地的实验室,为分析开发和分析校准提供非危险材料。该材料由SARS-CoV-2基因组的两个独特区域组成,长度约为4 kb核苷酸。采用RT-dPCR方法测定每个合成片段的浓度,并确认与RT-qPCR方法兼容。在本报告中,介绍了这种材料的制备、稳定性和局限性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Biologicals
Biologicals 生物-生化研究方法
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
48 days
期刊介绍: Biologicals provides a modern and multidisciplinary international forum for news, debate, and original research on all aspects of biologicals used in human and veterinary medicine. The journal publishes original papers, reviews, and letters relevant to the development, production, quality control, and standardization of biological derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern.Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.
期刊最新文献
Optimization of a U937 cell-based reporter system to assess ADCC activity of ustekinumab versus trastuzumab. Preparation of poloxamer-based CPV virus-like particle vaccine and its immunological evaluation in mice. Oral immunization with engineered probiotics expressing tcdB protects mice against Clostridioides difficile infection. Corrigendum to "Preparedness and response to emerging veterinary disease outbreaks - A meeting report" [Biologicals 93 (February 2026) 101873]. Aims and Scope/Editorial Board/Publishing Details
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1